Institut für Experimentelle und Klinische Pharmakologie und Toxikologie

CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Schenker H, Rech J, Tascilar K, Hagen M, Schoenau V, Sergeeva M, Selvakumar M, et al. Conference contribution PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) Rech J, Tascilar K, Schenker H, Sergeeva M, Selvakumar M, Konerth L, Prade J, et al. Conference contribution LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Rech J, Tascilar K, Schenker H, Hagen M, Sergeeva M, Selvakumar M, Konerth L, et al. Conference contribution Retronasal olfactory testing using candies sent by post and for screening purposes: a feasibility study (2020) Besser G, Tianxiang Liu D, Prem B, Iabloncsik D, Pablik E, Mueller CA, Renner B Journal article Regiospecific Introduction of Halogens on the 2-Aminobiphenyl Subunit Leading to Highly Potent and Selective M3 Muscarinic Acetylcholine Receptor Antagonists and Weak Inverse Agonists (2020) Fischer O, Hofmann J, Rampp H, Kaindl J, Pratsch G, Bartuschat A, Taudte V, et al. Journal article Matching sensitivity to abundance: High resolution immuno-mass spectrometry imaging of lanthanide labels and endogenous elements in the murine brain (2020) Clases D, De Vega RG, Funke S, Lockwood TE, Westerhausen MT, Taudte V, Adlard PA, Doble PA Journal article Unanswered Questions Reply (2020) Schlichtig K Journal article, Letter Strategies for neuroprotection in multiple sclerosis and the role of calcium (2020) Enders M, Heider T, Ludwig A, Kürten S Journal article, Review article Body-Mass-Index Associated Differences in Ortho- and Retronasal Olfactory Function and the Individual Significance of Olfaction in Health and Disease (2020) Besser G, Erlacher B, Aydinkoc-Tuzcu K, Liu DT, Pablik E, Niebauer V, Koenighofer M, et al. Journal article Medication Safety in Patients Treated with New Oral Antitumor Agents: A Prospective, Randomized Investigation on the Impact of Intensified Clinical Pharmaceutical/Clinical Pharmacological Care on Patient Safety and Well-Being (AMBORA). Supported by the German Cancer Aid (70112447) within the Comprehensive Cancer Center Erlangen-EMN (2020) Schlichtiq K, Duerr P, Fromm M, Dörje F Conference contribution